|
Architects of Alliances 2008: Issues and Opportunities in Due Dilgence Reviews, a Business Development Course. September 10-11, University Club Toronto, Ontario Successfully completing deals requires a full and complete Due Diligence process. To put together a better deal, due diligence is a process in which the buyer typically attempts to learn everything there is to know about a product opportunity in hopes of putting together a better deal, and the seller learns more about the partner/acquirer of his technology and what the working relationship will be like. However most deals fall apart during the due diligence process, and it is thought that the due diligence success rate is about 15%. Despite the obvious importance of this process there is no right/wrong way to do due diligence, and there are few learning opportunities other than on the job training. This course will appeal to those who are involved in deal-making, either with technologies to license or looking for products to be acquired, and specifically will help with the multidisciplinary approach common to today’s due diligence environment, including the need to bring together financial, development, regulatory and other disciplines in order to successfully manage the due diligence process and complete deals. Topics covered will be of interest to: - CEO’s, CFO’s - Licensing and Business Development - Marketing and New Product Development - Legal Counsel /Intellectual Property - Financial Officers/Investment Analysts - University Technology Transfer - Strategic Planning and Project Management - R&D and Development Team - Alliance Management - Regulatory Affairs - Others asked to Assist with Due Diligence The course content was developed in conjunction with the Education Subcommittee of the Canadian Healthcare Licensing Association (CHLA) For Details, Contact CHLA (www.chlassoc.com) or Dan Vickery (dan@bioensemble.com) Cell: 412-877-7944 |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |